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Introduction The burden of typhoid fever remains high in impoverished settings, and 
increasing antibiotic resistance is making treatment costly. The purposes of 
this study were: to compare the costs and the effectiveness of typhoid 
programs between oral and injection treatments in pediatric patients at 
Songkhla Hospital.
Methods This study was an incidence-based cost-of-illness analysis from providers’ 
perspective. Micro-costing approach was employed for calculating patient-
specific data. The study was conducted in Songkhla Hospital in the southern 
part of Thailand from 2009 to 2010. The total number of the cases was 78. 
Patients taking antibiotics for 48 hours, and those suspected of having 
complicated typhoid fever like peritonitis, ileus, toxic encephalopathy were 
excluded. We collected and reviewed medical records. In all provisionally 
selected children, blood was drawn for complete blood count, widal test and 
blood culture. The statistics used in data analysis were descriptive statistics 
and the cost-effectiveness of typhoid treatment with the two methods was 
compared using independent t-test.
Results The results of the study revealed that the average cost of typhoid treatment 
with oral Ciprofloxacin calculated with DRG was 3,301.88 baht which was 
lower than that of injection Ceftriaxone treatment calculated with DRG 
(3,615.05 baht). When the operation costs were considered, the results of the 
study remained the same, i.e. the treatment cost of typhoid with oral 
Ciprofloxacin was two times lower than that with injection Ceftriaxone. The 
average cost of the oral treatment was 2,844.45 baht, and that of the injection 
treatment was 5,303.19 baht. Regarding the effectiveness of typhoid 
treatment with Ciprofloxacin measured from the time the fever was reduced, 
it was found that the body temperature of the two methods of treatment were 
used was not significantly different (p<.05). The patients on oral medications 
had a fever for an average of 3.36 days while those on injection treatment had 
a fever for an average of 3.76 days. However, the lengths of stay (LOS) of 
the two groups of patients were significantly different.
Conclusions The results of this study showed that the cost-effectiveness of oral treatment 
was better than injection. Bedside, the patient and caregiver spent less time 
when oral treatment was administered than when injection treatment was 
used. Therefore, the direct cost for treatment was reduced and the indirect 
cost as a result from LOS was also reduced. Above all, the patient did not get 
pain from injection while the effectiveness of fever reduction was not 
different.
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INTRODUCTION
Typhoid fever (TF) has been an important health 
problem in many parts of the world. Typhoid fever 
is a major cause of morbidity and mortality with an 
estimated global incidence of 21.6 million cases1. 
In developing countries, its annual incidence ranges 
from 12 to 622/100000 persons. Salmonella 
enterica serovar Typhi (S. Typhi) is responsible for 
the majority of cases followed by S. enterica
serovar Paratyphi A (S. Paratyphi A) that causes 
20% of the cases2-4. In Thailand, TF is occasionally 
endemic in temporary shelters along the Burmese 
border and usually the Multidrug-Resistant 
Salmonella Typhiz (MRD). In the southern part of 
Thailand, TF endemics began during 2009-2011 
and it has been continuously found in Songkhla 
Province where TF is most prevalent among the
five lower southern provinces 5-7. There are 
published reports that cefixime a third generation 
of oral cephaplosporin is effective in treating 
typhoid fever and well practiced in typhoid 
fever8,9,10,11.
Oral ciprofloxacin fluroquinolone group is 
widely used in pediatric infectious diseases and 
mostly similar to cephaplosporin in its 
pharmacological and antimicrobial properties but 
cheaper than cephaplosporin12-18. Now, there are no 
published controlled studies evaluating oral 
ciprofloxacin and intravenous ceftriaxone in 
typhoid fever. We, therefore, undertook the study 
where we prospectively health economics 
evaluated the medical costs and effectiveness of 
oral ciprofloxacin and intravenous ceftriaxone 
therapy for children sign from used blood culture 
as the standard for comparison or confirmed 
typhoid fever and compare with that of intravenous 
ceftriaxone with a hypothesis that oral 
ciprofloxacin is effective in treating typhoid fever. 
We opted for ceftriaxone because, firstly, there are 
reports that ceftriaxone is more effective for 
typhoid fever in children19 and the costs are likely 
to be lower than cefotaxime. Secondly, cefotaxime 
needs to be injected 3-4 times a day while 
ceftriaxone is administered only 1-2 times a day.
This study was an attempt to estimate the cost and 
effectiveness of typhoid programs between oral and 
injection in pediatric patients at Songkhla Hospital. 
We, therefore, undertook this a study where we 
prospectively evaluated the cost and clinical 
effectiveness of oral therapy and intravenous 
ceftriaxone therapy for children is effective, safe 
and cheaper oral option for treatment of typhoid 
fever in children.
Definition of Term
Costs of treatment refer to expenses in treatment of 
typhoid fever with ciprofloxacin and intravenous 
ceftriaxone calculated using operational costs
(laboratory cost, pharmacy cost, routine service 
cost).
Diagnosis-related group (DRG) is used to 
determine how much money health care providers 
will be given to cover future procedures and 
services, primarily for inpatient care.
Effectiveness refers to the results of 
treatment of typhoid fever with ciprofloxacin and 
intravenous ceftriaxone; in this study, clinical 
effectiveness and the lengths of stay (LOS) were 
measured.
METHODS
The study was conducted in Songkhla Hospital in 
the southern part of Thailand from November 2009 
to February 2010. Children between 1 year to 14 
years with clinical feature suspected of typhoid 
fever were assessed for eligibility (proved by blood 
culture positive for Salmonella Typhi 
(Hemoculture for Salmonella Typhi using Mac 
Conkey agar, sensitivity tests using the disc 
diffusion method, stool cultures using selective 
media agar plates). The total number of cases was 
78. Patients taking antibiotics for 48 hours, and 
being suspected of complicated typhoid fever and 
toxic encephalopathy were excluded. We collected 
and reviewed medical records. 
In all provisionally selected children, 
blood was drawn for a complete blood count, widal 
test and blood culture. However, only culture 
confirmed typhoid fever was finally enrolled for 
RCT. Children were enrolled in the study after 
approval of the ethical review committee of the 
hospital. Eligible children were allotted double 
blind RCT to received oral ciprofloxacin (15-20 
mg/kg/day divided every 12 hours for the 
experimental group or EG) and intravenous 
ceftriaxone (70-100 mg/kg/day divided every 12 
hours for the control group or CG). Simple 
Randomization technique was done using a table 
sampling.
After being discharged, the patients were 
given appointments to come to the OPD for follow-
ups: one week after the discharge to check their 
clinical wellbeing and whether they had completely 
taken medications prescribed for them, and then 6-
8 weeks after that for rectal swab cultures. Clinical 
defervescence was defined as temperature below 
37.80C for at least 24 hours without antipyretic. A 
satisfactory clinical response or clinical 
effectiveness was defined as complete resolution of 
all presenting symptoms and signs, clinical failure 
were defined as persisting fever more than 7 days20. 
Hence, types of cost for this study were the 
following: 1) Laboratory cost consisting of 
practical laboratory investigations. 2) Pharmacy 
cost equaled acquisition drug cost plus drug-
dispensing cost. 3) Routine service cost was the 
sum of outpatient and inpatient service. 4) Total 
cost or total treatment cost consisting of all costs 
mentioned above (points 1, 2, and 3). For this 
study, resources used by the hospitals and service 
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outputs were collected from the official records of 
the two hospitals. The hospital-related data were 
collected for the 2009-2010 financial year. 
Descriptive statistics were used. 
RESULTS
In this study, 78 children were assessed for 
suspected typhoid fever (oral ciprofloxacin = 11, 
intravenous ceftriaxone = 67). The sample size for 
oral cases was small because when children were 
sick and admitted, most of them were not ready to 
take the medicine orally as it was bitter; however, it 
was necessary to give them immediate treatment, 
and therefore, injections were given for their safety.
This is why the number of the oral cases was 
limited. The two groups showed similar clinical 
responses with similar defervescence in days (oral 
ciprofloxacin (OC) vs intravenous ceftriaxone (IC) 
and similar clinical cure with only one clinical 
failure in each group on subsequent blood culture. 
No relationship was found between pretreatment 
febrile illness in days and clinical cure (r= .0023, 
p=0.71) and no significant relationship was found 
between nutritional status and days required 
defervescence (r= 0.042, p=0.66) (Table 1). 
Table 1: Comparison of baseline characteristics, clinical and bacteriological responses in the two sample groups
Baseline characteristics Oral ciprofloxacin (OC)
(n=11)
Intravenous ceftriaxone (IC)
(n=67)
Age in years 7.5+2.58 7.63+2.88
Male:Female 3:8 25:22
Initial temperature 39.59+2.30 39.60+2.11
Deferverscence in days 3.36+1.8 3.76+.18
Bacteriological cure 11/11(100%) 67/67(100%)
No significant side effects were observed 
during the course of therapy in the two (Results of 
significance for deferverscence in days between 
oral ciprofloxacin and intravenous ceftriaxone was 
p=0.29 and results of significance for clinical cure 
between oral ciprofloxacin and intravenous
ceftriaxone was p=.70 (Table 2).
Table 2: Comparison of baseline complete blood count (CBC) between oral ciprofloxacin and intravenous 
ceftriaxone
Clinical data Oral ciprofloxacin Intravenous ceftriaxone t-value p-value
HCT 36.74+.82 35.29+.42 1.33 .18
WBC 7045.45+500.43 7132.09+2517.89 -.11 .91
LYMP 26.87+3.78 31.76+1.44 -1.26 .21
PMN 65.75+4.07 60.31+1.68 1.22 .21
PLT 230909.09+22713.81 180480.00+9143.35 2.09 .06
Treatment cost for this study was obtained 
by multiplying the unit cost of medical services and 
quantity of the services used. The two groups 
included in this study were quite different due to 
treatment costs based on actual situation (base 
case). When the treatment costs were compared 
between the two methods, it was found that the 
average operational costs of treatment using oral 
ciprofloxacin was 2,844.45 baht which was lower 
than that using intravenous ceftriaxone, for which 
the average costs was 5303.19 baht. And on 
comparing the expenses calculated with DRG. 
Diagnosis-related group (DRG) is used to 
determine how much money health care providers 
will be given to cover future procedures and 
services, primarily for inpatient care. It was found 
that the average costs of treatment using oral 
ciprofloxazine was 3,301.88 baht which was lower 
than that of treatment using intravenous ceftriaxone 
which was 3,615.05 baht (Table 4).
Table 3: Comparison of costs between oral ciprofloxacin and intravenous ceftriaxone 
Type of antibiotics used in treatment Operational costs DRG
Mean SD. Mean SD.
Oral ciprofloxacin 2,844.45 587.02 3,301.88 190.35
Intravenous ceftriaxone 5,303.19 381.04 3,615.05 1522.94
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From Table 3, when effectiveness of the 
two methods of treatment for typhoid fever was 
compared, it was found that oral ciprofloxacin was 
significantly more effective in terms of length of 
stay (p=.00) but in terms of clinical effectiveness, 
the difference was not statistically significant .
Table 4: Comparison of effective variables (body temperature and length of stay or LOS) between oral 
ciprofloxacin and intravenous ceftriaxone
Effective variables Oral ciprofloxacin Intravenous ceftriaxone t-value p-value
Body temperature 37.04+.18 36.91+.18 .79 .43
Length of stay 3.36+.45 3.76+.28 -3.68 .00
The treatment results revealed a 100% 
clinical cure, neither clinical failure nor 
microbiological failure was found (after the 
complete treatment, rectal swab culture was carried 
out during the 6th -8th week and no Salmonella 
Typhi was found). Clinical relapses and chronic 
carriers were not found. The fever clearance time 
of the group using ciprofloxazin was 3.36 days and 
that of the initial intravenous ceftriaxone was 3.76 
days, so the difference was not statistically 
significant. However, the LOS for the oral group 
was shorter than that for the group that had initial 
intravenous ceftriaxone, 1.73 days and 4.39 days, 
respectively, and the difference was thus 
statistically significant. 
DISCUSSION
While comparing the treatment cost between 
treatments, it was found that  the oral ciprofloxacin 
had lower than that of the intravenous ceftriaxone, 
This was because during treatment, it was found 
that the children could take the oral medication 
very well; their temperature was lower, and some 
of them recovered quickly and their parents wanted 
to take them home. Therefore, follow-ups at home 
were used and as a result, the LOS was different. 
As routine service cost (at outpatient and inpatient 
departments) contribute 80 % of the total cost, a 
longer duration of stay of child led to higher 
treatment cost for them compared to the treatments. 
There are reports that ceftriaxone is more effective 
for typhoid fever in children and the costs are likely 
to be lower than cefotaxime19. A study in urban 
slums of Deli in 1996 found that A study in the 
urban slums of Delhi in 1996 found that the 
average direct cost of blood culture-con-firmed 
typhoid, blood culture-confirmed paraty-phoid, and 
clinical typhoid wan Rs 277, Rs 74, and Rs 432 
respectively. These costs were converted into Us 
dollar in 2004 rate, and the same stood at US$ 
12.14, 7.63, and 18.94 respectively20-21. The present 
study also calculated the average treatment cost of 
blood culture-confirmed typhoid, blood culture-
confirmed paratyphoid, and Widal test-postitive 
cases. However, the sample size of the subgroups 
was too small to present the means separately. 
Hence, the average treatment cost was reported, 
and it was US$94.80 and US$176 .77 (oral
ciprofloxacin = 2,844.45 bath and intravenous 
ceftriaxone = 5,303.19 bath) which was quite 
different to the average treatment cost found in the
study in Thailand. Both DRG were nearly equal to 
the costs associated with two treatments. 
Diagnosis-related group (DRG) is used to 
determine how much money health care providers 
will be given to cover future procedures and 
services, primarily for inpatient care22.
In addition, in this study, neither adverse 
events nor side effects of the two drugs were found; 
only the bitter taste of ciprofloxazone that made it 
difficult for patients to take it orally and as a result 
they vomited (Ciprofloxazone was made into syrup 
for small children). We tried to select drugs that are 
effective for complete cure and with no chronic 
carriers in order to prevent the spread of the 
disease. Therefore, we chose to use ciprofloxacin 
and ceftriaxone as our drugs of choice for treatment 
of typhoid fever that was endemic at that time. We 
used oral ciprofloxacin 15-20 mg/kg/day bid 14 
day (the regimen recommended by the 
manufacturers) or started with initial intravenous 
ceftriaxone 70 -100 mg/kg/day twice a day until the 
fever decreased or clinical well being was seen 
(increasing appetite, and looking well). Then the 
drug was changed to oral ciprofloxacin 15-20 
mg/kg/day bid 14 days, too. We administered the 
drug for 14 days because we wanted a complete 
cure so that there would be no relapse and chronic 
carrier23-25. We chose to use ceftriaxone because 
firstly, it is more effective for treatment of typhoid 
fever in children than cefotaxime, and secondly, 
cefotaxime needs to be injected 3 - 4 times a day 
while ceftriaxone could be administered only 1-2 
times a day26.
Salmonella Typhoid is an intercellular 
organism. Therefore, factors influencing the 
efficacy of antibiotics in decreasing the relapse rate 
include bacteriostatic effectiveness, the ability to 
penetrate the intracellular environment and the 
appropriate dose with appropriate duration of
therapy23. Fluorquinolones24and third generation 
cephalosporins have a better profile in this. It was 
also found that ciprofloxacin could reduce fever 
faster than ceftriaxone26. Adverse effects of 
ciprofloxacin on cartilage and growth in humans 
have not been clearly reporte14, 27 and we, 
consequently, decided to use it because the drug 
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has clinical cure and is without chronic carriers. It 
was found that the effectiveness of both groups of 
medicine was not different; all the patients were 
completely cured; had no relapses and no chronic 
carriers but the medical costs were significantly 
different. The costs can be even higher taking into 
account the expenses of the caregiver, his/her 
absence from work, etc. This is because during 
treatment, it was found that the children could take 
the oral medication very well; their temperature 
was lower, and some of them recovered quickly 
and their parents wanted to take them home. 
Therefore, follow-ups at home were used and as a 
result, the LOS was different. Last, the treatment 
that could get rid of a carrier stage could help 
control the disease28, 29. Public health officers were 
asked followed up the cases on the phone and 
found that the patients did not vomit after taking 
the medicine orally. The officers also monitored if 
the patients received the medication according to 
the prescription; whether there were anything 
problems such as nausea, diarrhea, rashes, or fever. 
If there were any problems, parents could bring the 
children to see the doctor immediately.
CONCLUSIONS
From the study results, we concluded that oral 
ciprofloxacin is effective. Our study suggests oral 
ciprofloxacin is safer and cheaper than the oral 
option for treatment of typhoid fever in children. 
Effective typhoid fever measures in this study, as in 
other areas in the topics, require integration of 
intensive health education as a public health tool, 
provision and access to safe water supply and 
adequate strengthening of health systems.
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